Blume-Jensen Peterinsider trades
In SEC Form 4 filings, Blume-Jensen Peter is listed as President and CEO of Acrivon Therapeutics, Inc. (ACRV). In the last 90 days, Blume-Jensen Peter sold $31K of Acrivon Therapeutics, Inc. (ACRV) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ACRVAcrivon Therapeutics, Inc. | President and CEO | 1 | Aug 27 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-27
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.